What test confirms peritoneal carcinomatosis in a patient with ascites?

Diagnostic Confirmation of Peritoneal Carcinomatosis from Ascites

Ascitic fluid cytology is the single best test to confirm peritoneal carcinomatosis, achieving a sensitivity approaching 100% when three samples are promptly processed. 1

Primary Diagnostic Approach

Paracentesis with cytologic analysis should be performed first in any patient with suspected peritoneal carcinomatosis presenting with ascites. 2

• Send three separate ascitic fluid samples for cytology to maximize diagnostic yield, which provides 96.7% sensitivity for detecting peritoneal disease. 2
• Cytology is uniformly positive (96.7% of cases) in patients with peritoneal carcinomatosis without massive liver metastases. 3
• The test is highly specific and avoids the false-positive results seen with "humoral tests of malignancy" like fibronectin or cholesterol, which are elevated in tuberculous peritonitis, cardiac ascites, and pancreatitis. 1

Complementary Ascitic Fluid Analysis

When cytology is obtained, simultaneously analyze the following parameters to support the diagnosis:

• Serum-ascites albumin gradient (SAAG): Peritoneal carcinomatosis typically shows a low SAAG (<1.1 g/dL), indicating non-portal hypertension-related ascites. 3
• Ascitic fluid protein concentration: Expect high protein levels (>2.5 g/dL) in peritoneal carcinomatosis. 3
• Hemorrhagic appearance: Bloody ascites with low white cell count and presence of atypical cells significantly favor carcinomatosis (positive predictive value <85%). 4

Serum Biomarker Assessment

Before any therapeutic intervention, measure serum tumor markers to guide diagnosis and exclude alternative etiologies:

• CEA, CA19-9, and CA-125: Elevated CEA and CA19-9 with normal or mildly raised CA-125 favors appendiceal origin; however, these are adjunctive and not diagnostic. 2
• Alpha-fetoprotein (AFP): Obtain in patients with known liver disease to distinguish hepatocellular carcinoma (which has negative ascitic cytology but elevated serum and ascitic AFP). 5, 3
• β-hCG and AFP in premenopausal women: Required to exclude germ-cell tumors when evaluating mucinous ascites. 2

When Cytology is Negative or Equivocal

Proceed directly to diagnostic laparoscopy with peritoneal biopsy if:

• Ascitic cytology is negative despite high clinical suspicion (negative cytology does not exclude low-volume or early peritoneal disease). 2
• The patient is a surgical candidate and requires definitive tissue diagnosis. 2

Laparoscopy provides 85% sensitivity and 100% specificity for confirming peritoneal disease through direct visualization and targeted biopsies. 2, 4

• Laparoscopy is the "gold standard" when routine tests fail to disclose the source of exudative ascites. 4, 6
• Peritoneal biopsies under videolaparoscopy are essential because macroscopic appearance alone can be misleading (typical appearance seen in only 29% of carcinomatosis cases). 4

Critical Pitfalls to Avoid

• Do not rely on CT imaging alone: Contrast-enhanced CT has limited sensitivity (28-51%) for peritoneal disease despite high specificity, so negative CT does not rule out peritoneal carcinomatosis. 2
• Do not order PET-CT for mucinous lesions: Mucinous peritoneal tumors exhibit low FDG uptake, limiting diagnostic utility. 2
• Do not pursue "humoral tests of malignancy": Ascitic fibronectin, cholesterol, and LDH are nonspecific and generate false-positives in tuberculous peritonitis and other benign conditions, leading to unnecessary workup. 1
• Recognize that negative cytology cannot definitively exclude peritoneal carcinomatosis, especially in early presentations or when massive liver metastases are present (only 13.3% of these patients have positive cytology). 2, 3

Algorithmic Summary

1. Perform paracentesis immediately → send three samples for cytology
2. Simultaneously analyze: SAAG, protein, cell count, appearance
3. Obtain serum markers: CEA, CA19-9, CA-125, AFP (if liver disease present)
4. If cytology positive → diagnosis confirmed
5. If cytology negative but high suspicion → proceed to diagnostic laparoscopy with peritoneal biopsy